Fig. 8From: Hsa_circ_0000098 is a novel therapeutic target that promotes hepatocellular carcinoma development and resistance to doxorubicinSchematic illustration of the role and mechanism of circ_0000098 in HCC. Circ_0000098 promotes HCC development through the miR-383/MCUR1 axis. Targeting circ_0000098 with DOX/sh-1@PLT may represent a feasible and practicable method for reducing DOX resistance in HCCBack to article page